Health Catalyst, Inc.

NASDAQ:HCAT

7.68 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Revenue 75.90274.72375.08473.77373.21373.86869.16268.35470.63368.08764.71661.73759.62755.84653.27947.19143.25945.11643.50139.42336.80435.21336.08432.86822.9920.632
Cost of Revenue 50.49648.62652.8441.78739.43838.30438.10636.3434.60733.99633.87733.08630.05327.33826.52824.35223.12924.06821.67718.63217.7117.32618.72716.99712.51811.61
Gross Profit 25.40626.09722.24431.98633.77535.56431.05632.01436.02634.09130.83928.65129.57428.50826.75122.83920.1321.04821.82420.79119.09417.88717.35715.87110.4729.022
Gross Profit Ratio 0.3350.3490.2960.4340.4610.4810.4490.4680.510.5010.4770.4640.4960.510.5020.4840.4650.4670.5020.5270.5190.5080.4810.4830.4560.437
Reseach & Development Expenses 13.65614.22617.03717.66717.5917.08219.61420.7718.14817.14817.47916.38514.52414.34514.97813.3912.06113.08813.04313.4779.7110.02210.56110.8398.4878.705
General & Administrative Expenses 14.36314.56415.4313.62523.67123.83316.1519.19217.5368.82325.33823.05622.52515.01528.12913.2978.1139.7018.3811.0136.1466.1745.9425.6057.2413.902
Selling & Marketing Expenses 12.74519.05817.27115.08416.39718.56920.37325.40120.92220.81821.86320.80816.70515.65114.79314.62912.50213.48711.70514.72110.38510.47311.62713.77112.0046.721
SG&A 23.85129.15726.6728.70940.06842.40236.52344.59338.45829.64147.20143.86439.2330.66642.92227.92620.61523.18820.08525.73416.53116.64717.56919.37619.24510.623
Other Expenses -0.016-0.0220.021-0.0280.00610.99411.66412.37212.61211.6490.014-0.0150.0010.024-0.0180.0090.064-0.0050.005-0.0020.020.0090.0060.004-0.0380.036
Operating Expenses 37.50743.38343.70756.56668.39370.47867.80177.73569.21858.43875.60470.961.89352.82565.67346.29735.7739.15335.49641.52728.45728.98130.2932.36629.28320.878
Operating Income -12.101-17.286-21.463-24.58-34.618-34.914-36.745-45.721-33.192-24.347-44.765-42.249-32.319-24.317-38.922-23.458-15.64-18.105-13.672-20.736-9.363-11.094-12.933-16.495-18.811-11.856
Operating Income Ratio -0.159-0.231-0.286-0.333-0.473-0.473-0.531-0.669-0.47-0.358-0.692-0.684-0.542-0.435-0.731-0.497-0.362-0.401-0.314-0.526-0.254-0.315-0.358-0.502-0.818-0.575
Total Other Income Expenses Net -1.345-3.188-8.7062.6072.091.7931.0220.142-1.18-1.6620.014-0.0150.0010.024-0.0180.009-8.514-0.0050.005-0.0020.02-1.6610.0060.004-0.0380.036
Income Before Tax -13.446-20.474-30.169-21.973-32.528-33.121-35.723-45.579-34.372-26.009-49.141-46.672-36.026-28.269-42.994-27.312-27.179-18.726-14.167-21.395-10.683-13.709-13.568-16.869-19.317-12.365
Income Before Tax Ratio -0.177-0.274-0.402-0.298-0.444-0.448-0.517-0.667-0.487-0.382-0.759-0.756-0.604-0.506-0.807-0.579-0.628-0.415-0.326-0.543-0.29-0.389-0.376-0.513-0.84-0.599
Income Tax Expense 0.070.1130.1430.0590.0850.0690.0590.156-0.944-3.551-0.149-6.658-0.1920.1010.0240.0140.004-1.2360.0990.0210.0110.0110.0070.0070.007-0.156
Net Income -13.516-20.587-30.312-22.032-32.613-33.19-35.782-45.735-33.428-22.458-48.992-40.014-35.834-28.37-43.018-27.326-27.183-17.49-14.266-21.416-10.694-13.72-13.575-16.876-19.324-12.209
Net Income Ratio -0.178-0.276-0.404-0.299-0.445-0.449-0.517-0.669-0.473-0.33-0.757-0.648-0.601-0.508-0.807-0.579-0.628-0.388-0.328-0.543-0.291-0.39-0.376-0.513-0.841-0.592
EPS -0.23-0.35-0.53-0.39-0.58-0.6-0.66-0.84-0.62-0.42-0.94-0.82-0.8-0.65-1.01-0.68-0.71-0.47-0.39-0.76-0.31-0.49-0.49-0.61-0.7-0.44
EPS Diluted -0.23-0.35-0.53-0.39-0.58-0.6-0.66-0.84-0.62-0.42-0.94-0.82-0.8-0.65-1.01-0.68-0.71-0.47-0.39-0.76-0.31-0.49-0.49-0.61-0.7-0.44
EBITDA -1.444-5.98-10.441-14.39-23.883-23.92-25.081-33.349-19.951-12.555-33.841-31.558-23.719-16.325-31.149-18.477-12.546-15.228-11.304-17.434-7.147-8.48-10.595-14.179-17.168-10.131
EBITDA Ratio -0.019-0.08-0.139-0.195-0.326-0.324-0.363-0.488-0.282-0.184-0.523-0.511-0.398-0.292-0.585-0.392-0.29-0.338-0.26-0.442-0.194-0.241-0.294-0.431-0.747-0.491